Biostock Studio: After receiving the PMA, Integrum looks to the future with confidence
In an interview with Biostock, Rickard Brånemark, founder and Chairman of the Board at Integrum AB, describes how receiving the PMA from the American FDA will have a very significant and positive impact on the future of Integrum.In an interview with Biostock, Rickard Brånemark, founder and Chairman of the Board at Integrum AB, describes how receiving the PMA from the American FDA will have a very significant and positive impact on the future of Integrum. The long and arduous process of obtaining a PMA for a class III medical device is an amazing milestone that only a handful Swedish